BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-557@pharmaconomics
DTSTAMP:20260707T015338Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:RAPP Phase 1 — RAP-219 (estimated date)
DESCRIPTION:Phase 1 trial results for RAP-219 in long-acting injectable are due ~ Jan 1\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/2012593/000119312526005446/rapp-ex99_2.htm\n\nTrack it: https://pharmaconomics.com/e/557
URL:https://pharmaconomics.com/e/557
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:RAPP catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR